B60Assessing parental choice of lopinavir/ritonavir granules intake to improve child adherence at Baylor-Mwanza, TanzaniaE-posterDrug formulations for infants and children
B60Acceleration of pediatric ART regimen optimization during COVID-19 epidemic using self-learning for health care workers in MalawiE-posterDrug formulations for infants and children
B60Proof of principle oral dissolvable strip formulation for pediatric ARV prophylaxisE-posterDrug formulations for infants and children
B60Caregivers perception on paedriatic lopinavir/ritonavir formulations for HIV-infected children at Baylor Clinic, Mwanza, TanzaniaE-posterDrug formulations for infants and children
B60Low viral suppression in children < 3 years old on two protease inhibitor formulations in Kenya, 2015-2019E-posterDrug formulations for infants and children
B6Evaluation of new high-throughput platforms for the quantification of HIV-1 RNA in plasma to support scale-up of viral load testing in low- and middle-income countriesOn-demand oral abstract sessionViral load and CD4 measurement
B6More frequent viral load testing, with point-of-care tests has no impact on viral suppression in postpartum HIV-positive women in a randomized controlled trial in 2 clinics in Johannesburg, South AfricaOral abstract session with live Q&AViral load and CD4 measurement
B6Expanding HIV-1 VL PT programs using a simple innovative technologyE-posterViral load and CD4 measurement
B6Improving viral load testing coverage among children and adults during the COVID-19 pandemic using a quality improvement approach at Baylor College of Medicine Children's Foundation HIV Clinic, Kampala, UgandaE-posterViral load and CD4 measurement
B6A multipronged strategy to improve viral load testing coverage in LiberiaE-posterViral load and CD4 measurement
611 - 620 of 870 items